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Objective: To evaluate the improper use of antimicrobials during the postoperative period and its economic impact. Methods:
We conducted a prospective cohort study by collecting data from medical records of 237 patients operated on between 01/
11/08 and 31/12/08. Results: from the 237 patients with the information collected, 217 (91.56%) received antimicrobials.
During the postoperative period, 125 (57.7%) patients received more than two antimicrobials. On average, 1.7 ± 0.6 antimicrobials
were prescribed to patients, the most commonly prescribed antibiotic being cephalothin, in 41.5% (154) of cases. The direct
cost of antimicrobial therapy accounted for 63.78% of all drug therapy, this large percentage being attributed in part to the
extended antimicrobial prophylaxis. In the case of clean operations, where there was a mean duration of 5.2 days of
antibiotics, antimicrobials represented 44.3% of the total therapy cost. Conclusion: The data illustrate the impact of overuse
of antimicrobials, with questionable indications, creating situations that compromise patient safety and increasing costs in the
assessed hospital.
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INTRODUCTION
In the hospital environment, antimicrobials are among the most prescribed drugs, accounting for 20-50% of drug
expenditures 1. Their rational use is defined as the practice
of prescribing that results in the optimal indication, dosage,
route of administration and duration of a therapeutic or
prophylactic regimen, providing range of clinical success
with minimal patient toxicity and low impact on microbial
resistance 2.
The increase in bacterial resistance to various
antimicrobial agents entails difficulties in individual
therapeutic care and contributes to increased rates of
hospital infections. The use of antibiotics must be
judicious and restricted to some circumstances, as
misuse could bring the following consequences:
treatment or prophylaxis fai lure; adverse drug
interactions; medication errors; and increased bacterial
resistance to antimicrobials 3-5. These issues are still
directly related to the increased costs of treatment and,
consequently, health spending.
According to Abrantes et al. 6, apart from the
clinical consequences, there is still a social and personal
cost of inappropriate use of these drugs, which involves
increasing the length of stay, days not worked, school
absences, disability and death. Such implications justify
efforts towards knowing and rationalizing the use of
antimicrobials. Thus, rectifying the situation is today one of
the most complex challenges in the health care reform 7.
A surgical site infection is an important health
problem. It is estimated that in the U.S. 23 million operations
are performed annually, with the development of at least
920,000 wound infections 8. One of the alternatives to
minimize this problem is the use of antimicrobials.
Antimicrobial use in the perioperative period,
despite accepted as an adjuvant in prevention of infectious
disease, has not shown the expected large impact. Rather,
there was an increase in some cases of surgical wound
infection, besides the emergence of resistant strains.
However, programs that improved the use of antibiotic
prophylaxis demonstrated reduced incidence of infections
in clean operations, from 5.1% to 0.8%, in potentially
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contaminated ones, from 10.1% to 1.3%, and in
contaminated ones, from 21.9% to 10.2%. Though simple,
prophylaxis is often inadequate, particularly regarding the
early use of antibiotics, the repetition of doses during surgery,
and especially its prolonged postoperative use 9.
Systematic reviews 10,11 have shown that the
extension of prophylactic doses of antibiotics and the use
of antibiotic association most often do not cause any indivi-
dual benefit to patients of surgical specialties, increasing
hospital costs and exposing users to unnecessary risks.
The indiscriminate use of this therapeutic class
of drugs, coupled with the great capacity of adaptation of
microorganisms, enables the emergence of resistant strains,
which requires, in turn, research and synthesis of increasingly
expensive drugs, resulting in significant increases in
healthcare costs. Due to the great interest of antimicrobials
in all the welfare spending, particularly in highly complex
institutions, programs of control and rational use of
antimicrobials intend to reduce the direct costs of these
drugs and their side costs related to the development of
multidrug resistance, such as increases time and costs of
hospitalization, use of tests and procedures of greater
complexity and admittance to intensive care units 12,13.
This study aimed to evaluate the appropriateness
of antimicrobials use and its economic impact during the
postoperative period.
METHODS
We conducted a prospective, uncontrolled,
cohort study, which examined the use of antimicrobials for
patients who were hospitalized in postoperative wards of
the Sergipe Emergency Hospital, a large hospital admitting
patients exclusively from the Public National Health System.
We followed all patients who underwent a
surgical procedure, were transferred and hospitalized for
at least 48 hours in the postoperative wards in the period
between November 1st and December 31st, 2008. Data
were collected from patient’s records and transcribed to a
form designed for this research, with items composed of
closed, pre-coded questions, and open ones, which were
coded later.
The study protocol was approved by the Ethics
in Research Committee of the Sergipe State Department
of Health. The purposes of the study and its methodology
were informed to the Commission of Hospital Infection
Control (CHIC) and Service of Pharmaceutical Assistance
of the hospital, including the commitment to data
confidentiality.
The variables studied were related to the
epidemiology and treatment parameters of the study
population: age, gender, diagnosis, length of hospitalization,
potential contamination of the wound, parameters based
on the   Program of Infection Control 14, antimicrobials used,
time of antimicrobials use, drug interactions, interruptions
in the therapeutic regimen and direct costs of antimicrobial
therapy by type of operation, which included only the values
of purchasing the drugs, the spending on ancillary materials
(syringes, catheters, diluent) not being accounted, nor any
expenditure on human resources and maintenance of the
place of admittance. For encoding of the target drugs, we
used the Anatomical Therapeutic Chemical Classification
– ATC – model 15, while for the diseases, the International
Statistical Classification of Diseases and Related Health
Problems – ICD-10 16.
We considered a “break in therapeutic regimen”
when there were any discrepancy between what was
prescribed and what was administered, which resulted in
lack of administration or interruption of at least one dose
of the drug. For evaluation of drug interactions, we used
the Micromedex data base as reference 17. We evaluated
frequency and proportion of the collected data in descriptive
statistics.
RESULTS
We followed 237 patients, with an average stay
of about nine days, minimum of two and maximum of 58.
Of these, 180 (75%) were male. The mean age of patients
was 39 years, ranging between 12 and 85. We observed
that 68.2% of diagnoses were for categories S, T and X,
defined as “injury, poisoning and consequences of external
causes”.
Of the 237 patients enrolled in the study, 217
(91.56%) made use of antimicrobial postoperatively, with
a mean of 1.709 ± 0.6 medications per patient.
The total direct cost of employed drug therapies
in the followed patients represented an amount of
R$ 33,545.49, the antimicrobial therapy accounting for
approximately 64% of this value (R$ 21,395.86).
In the hospital where this study was conducted,
the antimicrobial commonly used in surgical prophylaxis
was cephalothin. The most commonly prescribed
medications during the postoperative period were:
cephalothin 41.5%, gentamicin 15% and clindamycin
12.9% (Table 1).
As to the classification of operations for potential
contamination of the incision described in the records, we
observed an increased number of surgical procedures
classified as potentially contaminated 24% (57), as
contaminated and 20.5% (48) of cases (Table 2 ). There
was no such information in 24% of records evaluated. The
notification of wound infection detection, as well as its
prognosis, were also not observed conducts.
During hospitalization, drug interaction occurred
in 23% (89) of 371 antimicrobial prescriptions (Table 3). Of
the interactions, 89.9% (80) were classified as
pharmacodynamic of greater severity. It was observed that
57 (26.2%) patients had break in therapeutic regimen
sometime during hospital stay.
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DISCUSSION
Most patients, 91.56%, made use of
antimicrobials during the postoperative period, which shows
a widespread use of this therapeutic tool in the study target
hospital.
Today, there is no doubt about the conceptual
validity of restricting the use of antibiotics as a strategy to
control the emergence of bacterial resistance, whose control
is related to reduction of cost, adverse events, and especially
mortality 18.
Approximately 30 to 50% of antimicrobials used
in hospitals are intended for surgical prophylaxis, the rate
of inappropriate use in these cases being estimated at 30
to 90% 19. According to the Guidelines for Prevention of
Nosocomial Infection proposed by the Brazilian Society of
Infectious Diseases 20, antibiotic use in surgical prophylaxis
should have parenteral presentation,  minimal toxicity and
cost, be a weak inducer of resistance and possess activity
against most pathogens causing surgical site infection in
the institution. For the Consensus of Rational Use of
Antimicrobial Agents21, first-generation cephalosporins are
the antimicrobials with the nearest profile and must be the
choice for most surgical specialties.
the available alternatives in the study hospital,
we found that the most commonly used drug, cephalothin,
is in accordance with the recommendations of the Brazilian
Society of Infectious Diseases 20 and of the Ministry of Health
21, for it is a first generation cephalosporin. However, both
references indicate cefazolin, not available in the institution
during the study, as the best alternative for having longer
half-life (two hours), thus covering operations of up to 3-4
hours duration. Cephalothin has a shorter half life (28
minutes), forcing the re-use every two hours of operation.
Besides greater intraoperative safety, the use
of cefazolin instead of cephalothin is better from the
economics point of view. According to data available on
the Ministry of Health price database 22, the average
cost of cephalothin for the system public hospitals is
around R$ 0.96, while cefazolin  costs on average
R$ 1.24. Since the repetition time of cephalothin dosage
is twice that of cefazolin, it would be a saving of
approximately 35% if the second therapeutic option was
opted for.
Antimicrobial prophylaxis in surgery is defined as
the use of antimicrobials for preventing surgical site
infections21. After finishing the procedure, the
contamination of the operative site is rare, though not
impossible. Therefore, in theory, additional doses of
antibiotics would not be indicated 23. We observed in this
study that the prolonged use of the same antibiotic used in
prophylaxis is a common conduct.
Although there is no record of infection diagnosis
in the medical records, the average time of use of
cephalothin after surgery was 6.32 ± 4.6 days. The mean
duration of antimicrobials in general was 6.6 ± 5.6 days.
Even in operations deemed “clean”, the average use of
antibiotics was 5.2 ± 4.1 days (Table 2). Only seven (15.5%)
patients who underwent surgical procedures considered
clean were not given postoperative antimicrobials. This
prolonged use of antimicrobials in clean operations
accounted for 44.33% (R$ 1,803.07) of the direct costs of
medical treatment.
It is known that prolonged antibiotic use
beyond the duration of the surgical procedure adds no
benefit to the therapy, however causing an increase in
the costs of prophylaxis and possibly the risk of developing
bacterial resistance. It is accepted also that the use of
prophylaxis is not indicated in many types of surgery,
especially in so-called clean operations and in those in
which there is not a perforated hollow viscus or need for
prosthesis placement 24.
Table 1 - Proportion of drugs prescribed and their mean time of use.
Drug % Mean time of use
Cephalothin1g 41.5 6.3 ± 4.6
Gentamicin 80mg 15.0 6.6 ± 5.7
Clindamycin 600mg 12.9 7.2 ± 6.5
Metronidazole 40mg/ml 8.62 4.1 ± 2.7
Ciprofloxacin 400mg 8.62 6.7 ± 3.8
Ceftriaxone 1g 5.60 8.2 ± 8.2
Cephalexin 500mg 2.15 9.6 ± 6.5
Cefepime 2g 1.60 10.3 ± 4.9
Vancomycin 500mg 1.36 7.0 ± 4.3
Ertapenem 1000mg 1.07 8.5 ± 4.9
Imipenem 500mg+Cilastatin 500mg 0.80 9.0 ± 3.5
Cefotaxime 1g 0.26 3.0 ± 0.0
Ciprofloxacin 500mg 0.26 7.0 ± 0.0
Sulfa 400mg+ Trimethropim 80mg 0.26 10.0 ± 0.0
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We observed that the prevalence of use of two
or more medications during the study period represented
57.7% (125) of the cases. Similar data in audits of surgical
wards showed prevalence of antimicrobial polytherapy in
53% of patients 25. Monotherapy for antibiotic prophylaxis
or treatment of infection is considered as an ideal situation
from the point of view of rational use and the prescriber
must be objective. Although there are indications for
combination therapy, its excessive use in clinical practice is
frequent, without support of protocols, with increased
exposure of the patient to medication errors 26,27.
The so-called “polypharmacy” or multiple drug
consumption is one of the main risk factors associated with
the prevalence of drug interactions in prescriptions. The
main interaction was found in the records between
cephalothin and gentamicin, in 86.5% (77) of interactions
with antimicrobial agents. This combination is associated
with nephrotoxic effect. A randomized, double-blinded study
in septic patients showed a higher incidence of
nephrotoxicity with combined use of gentamicin with
cephalothin 28.
Another serious problem detected was breaking
of the treatment regimen of patients followed, observed in
26% during the study. Strict control of schedules, the
dilutions and the intervals between doses of antibiotics is
necessary so as the effect between the maximum peak
and minimum level action required for bacterial killing be
the expected for effective treatment, preventing selection
of resistant organisms 28. Causes of discontinuation were
quantified and categorized as flaws in the prescribing
process, 31.9% of the cases, which include constant
changes of different attending physicians and failure to fill
the CHIC assessment report, with the resulting unauthorized
dispatch of the drug by the pharmacy; flaws in the nursing
process (56%) comprising omission of administration of any
dose, initial administration with subsequent interruption of
antimicrobials in patients without or refused CHIC report
assessment; and the pharmaceutical supply failures (12.1%)
that include shortages of drugs during the period.
Medication errors compromise patient safety and quality
of care, as they are associated with increased morbidity
and mortality, length of stay and health care costs and are
responsible for 78% of severe iatrogenic conditions 29,30.
The extension of  antimicrobials use beyond the
surgical period tends to bring an increase in risk to the
patient and also increases the costs of assistance 31. When
the time of use of these drugs for less than three days  is
compared with the cases of longer periods, there is a
proportional increase in the number of drug interactions
(14.6% to 35.4%), breaks in therapeutic regimen (17.1%
to 40.3%) and a 58%  increased in the average cost
(R$ 11.65 to R$ 18.49).
From the above, it is possible to illustrate the
damage caused by failures in the use of antimicrobials in
patients undergoing surgical treatment. From the individu-
al point of view, it was noted that extensive use of antibiotics
was associated with users’ exposure to a greater number
of drug interactions and undue breaks in therapeutic
regimen. From the collective point of view, there was a
direct association with increased direct costs of care. Other
Table 2 - Proportion of operations, average usage time and total direct cost of antimicrobial therapy.
Type of operation* % Average usage Average cost of Total cost of antimicrobial
t ime ant imicrobia l therapy
Clean  19 5.2  ± 4.1 R$ 40.06 R$ 1.803.07
Potentially Contaminated  24 6.1  ± 4.7 R$ 22.48 R$ 1.259.11
Contaminated  20.5 7.8  ± 5.6 R$ 157.82 R$ 7.575.42
Infected  12.5 4.5  ± 1.9 R$ 235.45 R$ 7.063.69
Not informed  24 7.9  ± 6.8 R$ 64.81 R$ 3.694.57
Total 100 6.6  ± 5.6 R$ 90.27 R$ 21.395.86
* Classification of potential risk of contamination (Decree 2626/98 Ministry of Health).
Table 3 - Time of antimicrobial use, exposure to potential risks related to the use of these medications, and costs.
Time of ATM Use* ATM* prescription Discontinuation (%) DI+ (%) Average Cost / Day
Up to 3 days 116 20 (17.1) 17 (14.6) R$ 11.65
From 3 to 10 days 193 37 (19.2) 50 (25.9) R$ 13.21
Above to 10 days 62 25 (40.3) 22 (35.4) R$ 18.49
Total 371 82 (22.1) 89 (23.9) R$ 15.28
* ATM: Antimicrobial; + DI: Drug Interaction
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complications related to the indiscriminate use of these
drugs, such as adverse reactions, microbial resistance,
prolonged hospitalization or increased indirect costs, could
not be observed and can be the target of further work.
R E S U M O
Objetivo: avaliar o emprego de antimicrobianos relacionado ao seu uso inadequado e impacto econômico durante o período pós-
operatório. Métodos: foi desenvolvido um estudo de coorte prospectivo por meio da coleta de dados de 237 prontuários de
pacientes operados entre 01/11/08 e 31/12/08. Resultados: dos 237 pacientes com informações coletadas no estudo 217 (91,56%)
fizeram uso de antimicrobianos. Durante o pós-operatório, 125 (57,7%) pacientes utilizaram mais de dois antimicrobianos. Foi
prescrito, em média, 1,7 ± 0,6 antimicrobianos por paciente, sendo o antimicrobiano mais prescrito a cefalotina, em 41,5% (154) dos
casos. O custo direto da terapia antimicrobiana representou 63,78% de toda a terapia farmacológica, sendo esta grande porcen-
tagem atribuída em parte ao prolongamento da profilaxia antimicrobiana. No caso das operações limpas, onde houve um tempo
médio de uso de antimicrobianos de 5,2 dias, os gastos com antimicrobianos representaram 44,3% do custo total da terapia.
Conclusão: os dados exemplificam o impacto do uso excessivo de antimicrobianos, com indicações questionáveis e criando situações
que comprometem a segurança dos pacientes e aumento os custos no hospital avaliado.
Descritores: Anti-infecciosos. Uso de medicamentos. Antibacterianos/administração & dosagem. Custos de cuidados de saúde.
Economia médica.
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